American Century Companies’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMRX
S
VCM
OCM
American Century Companies's IMRX Position: Q1 2026 in Review
American Century Companies opened a new position in Immuneering (IMRX) in Q1 2026: 34,224 shares worth $180K. The stake represents ﹤0.01% of the portfolio and ranks #2726 among its holdings. This is a return to the name: American Century Companies previously reported a position in IMRX as recently as Q1 2024.
American Century Companies first reported a position in IMRX in Q3 2023 and has held it in 4 quarters since. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.
- American Century Companies held 34,224 shares of Immuneering worth $180K as of Q1 2026.
- Immuneering was a new American Century Companies position in Q1 2026.
- Immuneering made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2726 holding.
- American Century Companies first reported a position in Immuneering in Q3 2023 and has held it in 4 quarters since.
- 95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.